Detalhe da pesquisa
1.
Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues.
J Antimicrob Chemother
; 76(9): 2375-2379, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021755
2.
Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain.
HIV Med
; 22(5): 379-386, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369104
3.
Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
Clin Infect Dis
; 71(9): 2354-2362, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754695
4.
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.
HIV Med
; 20(6): 359-367, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31006980
5.
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.
J Viral Hepat
; 25(2): 180-186, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783247
6.
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.
Pharmacogenomics J
; 17(6): 551-555, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27241060
7.
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
Pharmacogenomics J
; 17(4): 360-365, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975229
8.
Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
HIV Med
; 18(8): 546-554, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116842
9.
Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.
Eur J Clin Microbiol Infect Dis
; 36(5): 853-861, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004322
10.
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.
Eur J Clin Microbiol Infect Dis
; 36(3): 487-494, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787664
11.
Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.
HIV Med
; 17(10): 766-773, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028546
12.
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.
Genes Immun
; 16(2): 134-41, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25569262
13.
Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance.
Eur J Clin Microbiol Infect Dis
; 34(11): 2171-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26254560
14.
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.
Eur J Clin Microbiol Infect Dis
; 34(10): 1929-36, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26155784
15.
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
Eur J Clin Microbiol Infect Dis
; 34(9): 1879-84, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115631
16.
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.
Eur J Clin Microbiol Infect Dis
; 34(11): 2247-55, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26342330
17.
Association of low-density lipoprotein receptor genotypes with hepatitis C viral load.
Genes Immun
; 15(1): 16-24, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173146
18.
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.
Eur J Clin Microbiol Infect Dis
; 32(11): 1427-35, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715768
19.
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV.
Infection
; 41(1): 21-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065463
20.
HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.
Pharmacogenomics J
; 17(6): 479-480, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779247